You’re Invited! Join us for this informative virtual event as Dr. Inderjit Mehmi will discuss new innovations with Combination Immuno-Oncology Therapy (I-O) for patients with metastatic melanoma and ongoing results from clinical trials, along with providing expert guidance and recommendations to facilitate appropriate integration of recently approved agents into current practice.
